Pharmaceuticals · PH-06 · Compliance with reference prices

A pricing error means fines and licence risk.

The Competition Committee found cases of markups exceeding the set limit in roughly 2,500 pharmacies, and the licences of six pharmaceutical companies were revoked. In 2026, prices of about 4,500 prescription medicines were revised.

Platform: Goods Flow

~686 thousand

Cases of medicine price inflation identified by the Competition Committee.1

21.1 bn

Estimated illegal income from these cases, UZS.1

~4.5 thousand

Prescription medicines whose prices were revised and reduced in 2026.2

When a reference price changes, the system should know before the pharmacy does.

Who it is for

Chain owner
Licence risk.
Commercial
Pricing policy.
Pharmacy manager
Price at the till.
Accounting
Reporting.

Where the problem lies

  • Manual pricing

    New reference prices are passed to pharmacies manually.

  • Markup not calculated

    The markup over the purchase price is not checked automatically.

  • Variation across the chain

    The same medicine is sold at different prices in different pharmacies.

  • No reporting

    The history of price changes is not stored.

How the loss is calculated

Finesnumber of cases × fine per case (UZS)
Refundsamount refunded to customers (UZS)
Licencedays of suspension × turnover (UZS per day)
Reputationlost customers

Calculate with your data

Late Price Updates After Reference Price Cuts: Customer Refund Exposure

This calculator estimates one risk for a distributor or pharmacy chain.

Use spaces for thousands and a dot or comma for decimals. Use the same currency throughout.

Values stay in this page and are not sent to the server.

Scenario estimate

0 / 5 values entered

Enter your operating figures to see the estimate.

This estimate excludes fines, consequences of licence suspension, reputational damage and lost customers, as well as administrative and system costs. These are different kinds of loss and are not added here. Not every sale above the permitted price necessarily leads to a refund, so treat the result as an upper-bound exposure. The target update time is set by you. Reaching it is not guaranteed and requires an audit and measurement. This is not legal advice and does not confirm any inspection outcome or compliance status.

Formulas and assumptions

This calculator estimates one risk for a distributor or pharmacy chain. When point-of-sale prices are updated late after a reference price cut, goods are sold above the permitted price. This creates an overcharged amount that may have to be refunded to customers. The estimate covers one month and uses your own observed data. It compares your current update time with a target update time that you set. The result is an estimated exposure, not a guaranteed saving.

Monthly refund exposure, current state
Formula: price decreases per month (cases/month) × current update time (hours) × sales per hour (units/hour) × overcharge per unit (currency/unit). The result is the amount overcharged per month that may have to be refunded.
Monthly refund exposure at target update time
The calculation is the same as for the current state, but the target update time (hours) replaces the current one. The result is in currency/month and is not guaranteed.
Exposure difference: current vs target
Formula: cases (cases/month) × (current time − target time, hours) × sales per hour (units/hour) × overcharge per unit (currency/unit). A negative result is shown as 0. This is an estimated reduction in exposure, not a guaranteed saving.

Facts and global practice

  • Competition Committee (kun.uz)

    About 2,500 pharmacies systematically exceeded the set maximum markup; illegal income was estimated at UZS 21.1 billion.1

  • Competition Committee (kun.uz)

    In Q1 2026, 110,500 cases were identified in more than 190 pharmacies; the licences of six companies were revoked.1

  • Pharmaceutical Agency

    Of 7,566 imported medicines, 2,620 had artificially inflated prices; reference prices were reduced for 1,970 medicines.3

  • kun.uz

    In 2026, prices of about 4,500 prescription medicines were reduced, with plans to reach 6,000 by year-end.2

Reference prices are updated frequently. Manual updating is a source of errors and delays.

Prices in the system, markups under automatic control

Reference prices and markup limits are updated centrally; the markup over the purchase price is checked automatically; if there is a deviation, the sale is blocked.

  1. 01Prices
    • Reference price
    • Update
    • History
  2. 02Receipt
    • Purchase price
    • Batch
    • Markup
  3. 03Sale
    • Till price
    • Check
    • Block
  4. 04Reporting
    • Deviations
    • Pharmacies
    • Audit

Modules

The current maturity level is shown next to each module.

Price and markup controlCentralisedEngineering capability
Till (POS) integrationWith a partner POSIn development
WMS: purchase price and batchDistributorCommercially available
Audit reportHistoryEngineering capability

How we start

  1. 01

    Price audit

    Processes and systems.

    Outcome: risk list.

  2. 02

    Pilot

    One chain.

    Outcome: deviation statistics.

  3. 03

    Scale-up

    All pharmacies.

    Outcome: full coverage.

  4. 04

    Subscription

    Monthly.

    Outcome: trend.

What is measured

Price deviationsCasesSystem
Update timeHoursSystem
Blocked salesCountTill
FinesAmountAccounting

What is needed to start

  • Commercial director
  • List of pharmacies
  • Till system
  • Price sources

What we do not promise

  • A fixed timeline and price without an audit
  • A GMP/GDP certificate or inspection outcome
  • Approving validation documents ourselves
  • Unmeasured results
  • Legal advice

Self-check

  1. Is the time (in hours) for a reference price change to reach pharmacies known?
  2. Is the markup checked automatically?
  3. Is a sale blocked when there is a deviation?
  4. Is price history stored?
  5. Are price differences between pharmacies visible?
  6. Is there a report available for inspections?
  7. Is the purchase price linked to the batch?
  8. Have staff been trained?
  9. Are fines analysed?
  10. Is there a responsible person?

Price audit

We review your price and markup process and show where errors arise.

  • Map of break points
  • Pilot plan
  • Implementation fee and monthly subscription

Sources

  1. «Over 2,500 pharmacies penalized for inflating medicine prices». kun.uz, 21.05.2026.
  2. «Referent narxlarga dorixonalarda qanday rioya qilinmoqda» [How pharmacies are complying with reference prices]. kun.uz, 14.07.2026.
  3. «Pharmaceutical Agency moves to cut inflated prices of thousands of medicines». kun.uz, 17.12.2025.